Back to search

Cornell University

Illuminating drug-induced arrhythmia mechanisms and stem cell-derived cardiomyocyte heterogeneity through rapid ionic current phenotyping

Abstract

dc:description.abstract

Cardiovascular disease is the leading cause of death in the United States, with over 10% of these deaths attributed to cardiac arrhythmias. We believe novel arrhythmia therapies developed over the coming decades have the potential to substantially improve patient outcomes through the use of increasingly sophisticated precision medicine tools. One such tool --- induced pluripotent stem cell-derived cardiomyocytes (iPSC-CM) --- provides a laboratory model for patient-specific investigations. These iPSC-CMs are currently used at academic medical centers to study arrhythmia mechanisms, and by pharmaceutical companies to study the proarrhythmic potential of drugs before clinical trials. While promising, these cells are limited by their relatively immature electrophysiological phenotype and cell-to-cell heterogeneity. Such shortcomings have adversely affected the reproducibility, consistency, and depth of insights from studies with these cells. In this thesis, we develop a novel approach called rapid ionic current phenotyping (RICP) that can be used to investigate the sources and extent of electrophysiological heterogeneity during iPSC-CM patch-clamp experiments. We use this method to study variations in physiology and patch clamp experimental artifact conditions that lead to the heterogeneous phenotype of iPSC-CMs. Based on these findings, we propose best practice methods to mitigate sources of electrophysiological heterogeneity during experiments and address their knock-on effects during post-processing. We use the RICP method in a drug cardiotoxicity screening pipeline, showing how we can acquire surrogate markers of cardiotoxicity and identify proarrhythmia mechanisms from the same iPSC-CM. Finally, we extend the RICP approach for use in an automated patch clamp system to demonstrate its potential in a high throughput setup that is more scalable in an industry setting. Ultimately, we believe RICP, together with insights it has provided in this thesis, has the potential to affect basic science arrhythmia research, and impact the way drugs are screened.

Degree

thesis:*
Name thesis:degree_name
Ph. D., Biomedical Engineering
Level thesis:degree_level
Doctor of Philosophy
Discipline thesis:degree_discipline
Biomedical Engineering
Grantor
Cornell University
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Clark, Alexander
Chair dc:contributor.chair
  • Christini, David
Committee members dc:contributor.committeemember
  • Doerschuk, Peter
  • Accardi, Alessio

Rights

dc:rights
Statement dc:rights
  • Attribution 4.0 International
Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Bibid
16176676
Dc Identifier Other
ProQuest Submission ID: 13529
ProQuest Publication ID: 30418353

Chain of custody

source
Harvested from
Cornell University
Base URL
ecommons.cornell.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Clark, Alexander. Illuminating drug-induced arrhythmia mechanisms and stem cell-derived cardiomyocyte heterogeneity through rapid ionic current phenotyping. Doctor of Philosophy thesis, Cornell University, 2023. https://hdl.handle.net/1813/114006